Table 3 Demography of angiographic findings and outcome
Variable | Study groups | P value | |||
|---|---|---|---|---|---|
Control (N = 359) | DM alone (N = 178) | HT alone (N = 382) | DM and HT (N = 315) | ||
Follow-up time (weeks) | 173.8 ± 106.8 | 155.4 ± 104.8 | 168.8 ± 99.7 | 160.9 ± 99.0 | 0.17 |
Number of diseased vessels | <0.01* | ||||
Single vessel disease | 206 (57.4%) | 74 (41.6%) | 186 (48.7%) | 124 (39.4%) | |
Dual vessel disease | 93 (25.9%) | 55 (30.9%) | 107 (28.0%) | 100 (31.8%) | |
Triple vessel disease | 60 (16.7%) | 49 (27.5%) | 89 (23.3%) | 91 (28.8%) | |
Mean of treated vessels | 1.6 ± 0.8 | 1.9 ± 0.8 | 1.7 ± 0.8 | 1.9 ± 0.8 | <0.01* |
Mean of treated lesions | 1.3 ± 0.7 | 1.4 ± 0.8 | 1.5 ± 0.8 | 1.6 ± 0.9 | <0.01* |
Type of intervention | 0.81 | ||||
Balloon angioplasty | 122 (30.0%) | 62 (15.2%) | 125 (30.7%) | 98 (24.1%) | |
BMS deployment | 144 (28.7%) | 60 (11.8%) | 171 (33.7%) | 131 (25.8%) | |
DES deployment | 116 (25.8%) | 68 (15.1%) | 137 (30.4%) | 129 (28.7%) | |
Lesion location | 0.62 | ||||
LAD | 249 (69.2%) | 138 (78.0%) | 288 (75.4%) | 183 (58.1%) | |
Lcx | 163 (45.2%) | 96 (54.2%) | 183 (48.0%) | 191 (60.6%) | |
RCA | 162 (45.0%) | 99 (55.9%) | 199 (52.0%) | 175 (55.6%) | |
SYNTAX score | 10.8 ± 8.0 | 11.9 ± 7.9 | 10.1 ± 6.9 | 11.6 ± 8.5 | <0.01* |
LVEF | 0.60 ± 0.13 | 0.55 ± 0.16 | 0.62 ± 0.13 | 0.59 ± 0.15 | 0.71 |
MI | 0.09 | ||||
yes | 15 (4.2%) | 14 (7.9%) | 12 (3.1%) | 17 (5.4%) | |
no | 344 (95.8%) | 164 (92.1%) | 370 (96.9%) | 298 (94.6%) | |
CV death | <0.01* | ||||
yes | 20 (5.6%) | 24 (13.5%) | 13 (3.4%) | 17 (5.4%) | |
no | 339 (94.4%) | 154 (86.5%) | 369 (96.6%) | 298 (94.6%) | |
All-cause death | <0.01* | ||||
yes | 35 (9.8%) | 36 (20.2%) | 21 (5.5%) | 22 (7.0%) | |
No | 324 (90.3%) | 142 (79.8%) | 361 (94.5%) | 293 (93.0%) | |
Re-PCI | 0.32 | ||||
yes | 84 (23.4%) | 51 (28.7%) | 82 (21.5%) | 73 (23.2%) | |
No | 275 (76.6%) | 127 (71.4%) | 300 (78.5%) | 242 (76.8%) | |